EN
TradingView
Ticker Trading Ideas Educational Ideas Scripts People
Profile Profile Settings Account and Billing Refer a friend My Support Tickets Help Center Ideas Published Followers Following Sign Out Go PRO Go PRO 30-day Free Trial Start free trial Go PRO Early
Markets US Stocks Health Technology Biotechnology

PHIO PHARMACEUTICALS CORP
NASDAQ
PHIO

PHIO
PHIO PHARMACEUTICALS CORP
NASDAQ
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Overview
Ideas Technicals

PHIO Stock Chart

Ideas

Videos only
PHIO supp x res
PHIO, 1D
PHIO: PHIO supp x res

PHIO - keep in mind of the event going into the week

PHIO
PHIO, 1D
Long
PHIO: PHIO

Phio Pharmaceuticals Corp Targets $phio
PHIO, 240
Long
PHIO: Phio Pharmaceuticals Corp Targets $phio

Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics that address unmet medical needs. Its clinical product candidate includes RXI-109, a RNAi compound developed for the reduction of dermal scarring in planned surgeries. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.

Technicals

Financials

Valuation
Enterprise Value/EBITDA, TTM —
Enterprise Value, FQ —
Market Cap — Basic —
Number of Employees —
Number of Shareholders —
Price/Earnings, TTM —
Price/Revenue, TTM —
Price/Book Ratio, FY —
Price/Sales Ratio, FY —
Balance Sheet
Current Ratio, FQ —
Debt to Equity, FQ —
Net Debt, FQ —
Quick Ratio, FQ —
Total Assets, FQ —
Total Debt, FQ —
Operating Metrics
Return on Assets, TTM —
Return on Equity, TTM —
Return on Invested Capital, TTM —
Revenue per Employee, TTM —
Price History
Average Volume (10 day) —
Beta - 1 Year —
Price - 52 Week High —
Price - 52 Week Low —
Dividends
Dividends Paid, FY —
Dividends per Share, FY —
Expected Annual Dividends —
Dividends Yield —
Margins
Net Margin, TTM —
Gross Margin, TTM —
Operating Margin, TTM —
Pretax Margin, TTM —
Income Statement
Basic EPS, Net Income —
Earnings per Share, Basic, TTM —
EBITDA, TTM —
Gross Profit, FY —
Last Annual EPS —
Last Annual Revenue, FY —
Net Income, FY —
Total Revenue, FY —
Free Cash Flow, TTM —

Profile

Sector: Health Technology
Industry: Biotechnology
Employees: 11
Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics that addresses unmet medical needs. Its clinical product candidate includes RXI-109, an RNAi compound developed for the reduction of dermal scarring in planned surgeries. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.

News

Community & tools
House rules Moderators People Pine Wizards Chat Brokers Stock Screener Forex Screener Crypto Screener Economic Calendar Shows
For business
Website & broker solutions Widgets Charting solutions Lightweight Charting Library Brokerage integration Advertising Partner program Refer a friend Content streams & RSS
Support
Help Center Pine Script Status page Blog Security vulnerability Contacts
About
How it works Features Pricing Wall of Love Terms of use Disclaimer Privacy policy Cookies policy Careers
© 2020 TradingView
Made with
Select market data provided by ICE Data Services
Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter
Profile Profile Settings Account and Billing Refer a friend My Support Tickets Help Center Ideas Published Followers Following Private Messages Chat Sign Out
Go PRO Go PRO 30-day Free Trial Start free trial Go PRO Early